ClinicalTrials.Veeva

Menu

Local Subfascial and Intramuscular Tranexamic Acid Administration in Pediatric Patient Undergoing Scoliosis Surgery, Double Blind Randomized Control Trial

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Blood Loss, Surgical
Scoliosis

Treatments

Drug: Tranexamic acid injection
Drug: Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT04622397
tranexamic acid in scoliosis

Details and patient eligibility

About

We hypothesized that local administration of tranexamic acid will minimize blood loss and blood product administration in pediatric patient undergoing scoliosis surgery

Full description

Spine surgery in paediatrics is frequently associated with substantial blood loss.

Blood product adminestration in children has many complications that are not fully known.

There are many modalities currently available to reduce blood loss in pediatric patients.

Tranexamic acid is tissue plasminogen activator inhibitor that reduce perioperative blood loss.

To date, no studies have investigated effect of local administration of tranexamic acid in pediatric population undergoing scoliosis surgery.

Enrollment

30 estimated patients

Sex

All

Ages

2 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children aged 2-12 years
  • Of both sexes
  • American society of anesthesiologist (ASA) physical status classification class I
  • Undergoing general anesthesia for scoliosis surgery

Exclusion criteria

  • Parents' refusal of regional block
  • Known allergy to tranexamic acid
  • Bleeding disorders (INR >1.4,Platelet count< 75000)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups, including a placebo group

Group T (tranexamic acid),n=15
Active Comparator group
Description:
Group T: tranexamic acid 10 mg/kg will be injected locally
Treatment:
Drug: Tranexamic acid injection
Group S (saline) (n=15)
Placebo Comparator group
Description:
Group S saline will be injected
Treatment:
Drug: Saline

Trial contacts and locations

0

Loading...

Central trial contact

Mina Adolf Helmy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems